651. Photopheresis treatment enhances CD95 (fas) expression in circulating lymphocytes of patients with systemic sclerosis and induces apoptosis.
- Author
-
Aringer M, Graninger WB, Smolen JS, Kiener HP, Steiner CW, Trautinger F, and Knobler R
- Subjects
- Adult, Aged, Cells, Cultured, Female, Humans, Lymphocyte Subsets immunology, Male, Middle Aged, Proto-Oncogene Proteins c-bcl-2 metabolism, Scleroderma, Systemic pathology, Scleroderma, Systemic therapy, Apoptosis, Lymphocytes immunology, Photopheresis, Scleroderma, Systemic immunology, fas Receptor metabolism
- Abstract
We investigated the effects of photopheresis in systemic sclerosis by analysing its influence on lymphocytes with regard to apoptosis and expression of bcl-2 and fas. Peripheral blood lymphocytes isolated immediately before and 24 h after photopheresis were investigated for apoptosis, bcl-2 and fas expression by fluorocytometry, and compared to controls. In addition, leucocytes from systemic sclerosis patients taken directly from the photopheresis system were tested for apoptosis after 24 h in culture. fas expression was similar in controls and patients with systemic sclerosis just before photopheresis, but increased 24 h after photopheresis, mainly due to an increase of CD4+CD95+ cells. bcl-2 was overexpressed in scleroderma peripheral lymphocytes, but not influenced by photopheresis. As compared to healthy controls, the percentage of apoptotic cells 24 h after photopheresis was high in cultured lymphocytes, but not ex vivo. The significant increase in fas on peripheral lymphocytes observed in this study may be a major operative mechanism of photopheresis in addition to (and possibly related to) the induction of apoptosis.
- Published
- 1997
- Full Text
- View/download PDF